Citations

Mayo Clinic

Showing 10 of 108572 citations.

Multimodality Imaging in Metabolic Syndrome: State-of-the-Art Review
Kalisz, Kevin , Navin, Patrick J. , Agarwal, Amit , Venkatesh, Sudhakar K. , Itani, Malak , Agarwal, Amit Kumar , Venkatesh, Sudhakar K , Rajiah, Prabhakar , Navin, Patrick , Rajiah, Prabhakar

RadioGraphics | February 8, 2024 | Volume: 44 | Issue: 3 | Pages: No page available

10.1148/rg.230083 | PMID 38329901 Get It

RadioGraphics Update: The 10 Pillars of Lung Cancer Screening—Rationale and Logistics of a Lung Cancer Screening Program
Adams, Scott , Flores, Efrén J. , Sharma, Amita , Lennes, Inga T. , Shepard, Jo-Anne O. , Fintelmann, Florian J. , Adams, Scott J , Sharma, Amita , Shepard, Jo-Anne O , Fintelmann, Florian J , Flores, Efren J , Little, Brent P.

RadioGraphics | February 8, 2024 | Volume: 44 | Issue: 3 | Pages: No page available

10.1148/rg.230057 | PMID 38329900 Get It

Gender Representation on Editorial Boards of JAMA Network Journals
Schaechter, Judith D. , Booth, Garrett S. , Dupont, William D. , Silver, Julie , Booth, Garrett , Jacobs, Jeremy W. , Silver, Julie K.

Journal of Women's Health | February 8, 2024 | Volume: 33 | Issue: 4 | Pages: 446-452

10.1089/jwh.2023.0685 | PMID 38330429 Get It

“To sleep—perchance to dream”: Daytime surgery start times for liver transplantation with ex situ normothermic machine perfusion
Das, Ian, Aqel, Bashar , Harnois, Denise M. , Mao, Shennen A. , Taner, C. Burcin , Croome, Kristopher P. , Aqel, Bashar A. , Harnois, Denise , Mao, Shennen A , Taner, Burcin , Croome, Kris P , Das, Ian

Liver Transplantation | February 8, 2024 | Volume: 30 | Issue: 7 | Pages: 763-767

10.1097/lvt.0000000000000344 | PMID 38329379 Get It

Reappraisal of large artery involvement in giant cell arteritis: a population-based cohort over 70 years
Elfishawi, Mohanad , Achenbach, Sara J., Crowson, Cynthia S. , Kermani, Tanaz A. , Weyand, Cornelia M. , Warrington, Kenneth J. , Elfishawi, M , Kaymakci, Mahmut S , J Achenbach, Sara, Crowson, CS , Kermani, Tanaz A , M Weyand, Cornelia, J Koster, Matthew, Warrington, Kenneth J , Kaymakci, Mahmut , Koster, Matthew J.

RMD Open | February 8, 2024 | Volume: 10 | Issue: 1 | Pages: e003775

10.1136/rmdopen-2023-003775 | PMID 38331471 Get It

Objective To evaluate the incidence and outcomes of large artery (LA) involvement among patients with giant cell arteritis (GCA) and to compare LA involvement to non-GCA patients. Methods The study included Olmsted County, Minnesota, USA residents with incident GCA between 1950 and 2016 with follow-up through 31 December 2020, death or migration. A population-based age-matched/sex-matched comparator cohort without GCA was assembled. LA involvement included aortic aneurysm, dissection, stenosis in the aorta or its main branches diagnosed within 1 year prior to GCA or anytime afterwards. Cumulative incidence of LA involvement was estimated; Cox models were used. Results The GCA cohort included 289 patients (77% females, 81% temporal artery biopsy positive), 106 with LA involvement. Reported cumulative incidences of LA involvement in GCA at 15 years were 14.8%, 30.2% and 49.2% for 1950–1974, 1975–1999 and 2000–2016, respectively (HR 3.48, 95% CI 1.67 to 7.27 for 2000–2016 vs 1950–1974). GCA patients had higher risk for LA involvement compared with non-GCA (HR 3.22, 95% CI 1.83 to 5.68 adjusted for age, sex, comorbidities). Thoracic aortic aneurysms were increased in GCA versus non GCA (HR 13.46, 95% CI 1.78 to 101.98) but not abdominal (HR 1.08, 95% CI 0.33 to 3.55). All-cause mortality in GCA patients improved over time (HR 0.62, 95% CI 0.41 to 0.93 in 2000–2016 vs 1950–1974) but remained significantly elevated in those with LA involvement (HR 1.89, 95% CI 1.39 to 2.56). Conclusions LA involvement in GCA has increased over time. Patients with GCA have higher incidences of LA involvement compared with non-GCA including thoracic but not abdominal aneurysms. Mortality is increased in patients with GCA and LA involvement highlighting the need for continued surveillance.
Nintedanib-Induced Colitis Can Mimic Inflammatory Bowel Disease
Odah, Tarek , Karime, Christian , Farraye, Francis A. , Farraye, Francis A , Hashash, Jana G.

ACG Case Reports Journal | February 8, 2024 | Volume: 11 | Issue: 2 | Pages: e01282

10.14309/crj.0000000000001282 | PMID 38333722 Get It

ABSTRACT Nintedanib is a medication that has been increasingly used for treatment of idiopathic and progressive pulmonary fibrosis. In this case series, we describe 3 patients with colitis symptoms associated with nintedanib use. Nintedanib discontinuation resulted in symptomatic resolution in all patients. Budesonide decreased symptoms in 1 patient. Clinicians should be vigilant in taking a thorough medication history and include nintedanib as a cause for gastrointestinal symptoms including colitis.
Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies
Diaz‐Galvan, Patricia , Przybelski, Scott A. , Lesnick, Timothy G. , Gunter, Jeffrey L. , Jack, Clifford R. , Min, Hoon‐Ki , Jain, Manoj , Miyagawa, Toji , Forsberg, Leah K. , Fields, Julie A. , Savica, Rodolfo , Graff‐Radford, Jonathan , Graff‐Radford, Neill R., Ferman, Tanis J. , Petersen, Ronald C. , Lowe, Val J. , Kantarci, Kejal , Figdore, Dan J, St Louis, Erik K, Min, Hoon-Ki Paul , Jack, Clifford R , Kantarci, Kejal , Ferman, Tanis J , Diaz-Galvan, Patricia , Algeciras‐Schimnich, Alicia , Figdore, Daniel J. , Schwarz, Christopher G. , Senjem, Matthew L. , Ramanan, Vijay K. , Jones, David T. , Botha, Hugo , Louis, Erik K. St. , Knopman, David S. , Graff‐Radford, Neill R. , Boeve, Bradley F.

Alzheimer's & Dementia | February 8, 2024 | Volume: 20 | Issue: 4 | Pages: 2485-2496

10.1002/alz.13653 | PMID 38329197 Get It

AbstractINTRODUCTIONPatients with dementia with Lewy bodies (DLB) may have Alzheimers disease (AD) pathology that can be detected by plasma biomarkers. Our objective was to evaluate plasma biomarkers of AD and their association with positron emission tomography (PET) biomarkers of amyloid and tau deposition in the continuum of DLB, starting from prodromal stages of the disease.METHODSThe cohort included patients with isolated rapid eye movement (REM) sleep behavior disorder (iRBD), mild cognitive impairment with Lewy bodies (MCI‐LB), or DLB, with a concurrent blood draw and PET scans.RESULTSAbnormal levels of plasma glial fibrillary acidic protein (GFAP) were found at the prodromal stage of MCI‐LB in association with increased amyloid PET. Abnormal levels of plasma phosphorylated tau (p‐tau)‐181 and neurofilament light (NfL) were found at the DLB stage. Plasma p‐tau‐181 showed the highest accuracy in detecting abnormal amyloid and tau PET in patients with DLB.DISCUSSIONThe range of AD co‐pathology can be detected with plasma biomarkers in the DLB continuum, particularly with plasma p‐tau‐181 and GFAP.
Dermatologic manifestations in pediatric patients with inflammatory bowel disease
Afarideh, Mohsen , Bartoletta, Katherine, Tollefson, Megha M. , Bartoletta, Katherine M.

Pediatric Dermatology | February 8, 2024 | Volume: 41 | Issue: 2 | Pages: 234-242

10.1111/pde.15538 | PMID 38326222 Get It

AbstractBackgroundDespite studies of dermatologic manifestations in adults with inflammatory bowel disease (IBD), little is known about the prevalence of IBD‐associated skin lesions and their correlation with IBD severity in children. We aimed to address these knowledge gaps in our single‐center cohort of children with IBD.MethodsRetrospective chart review of 528 children and adolescents (≤18 years old) with IBD and seen at Mayo Clinic (Rochester, MN) between 1999 and 2017 was conducted. The Chi‐Square/Fischer's exact test (with p ≤ .05 to signify statistical significance) was applied to compare categorical outcomes between Crohn's disease (CD) and ulcerative colitis (UC) patients.ResultsIn total, 425 IBD patients (64.9% CD, 53% males) and ≥1 dermatologic diagnosis were included. Presence of ≥1 cutaneous infection was recorded in 42.8% of participants. Acne was the most common non‐infectious dermatologic condition (30.8%), followed by eczema (15.8%) and perianal skin tags (14.6%). Angular cheilitis (p = .024), keratosis pilaris (KP, p = .003), and perianal skin complications (i.e., skin tags, fistula, and abscesses; all p < .001) were more frequently diagnosed among children with CD, while fungal skin infections (p = .017) were more frequently diagnosed in UC patients. Severity of IBD correlated with higher prevalence of perianal fistula (p = .003), perianal abscess (p = .041), psoriasis (p < .001), and pyoderma gangrenosum (PG, p = .003).ConclusionsBoth IBD‐specific and IBD‐nonspecific dermatologic conditions are very prevalent in childhood IBD, the most common being infectious. Children with CD are more likely to experience angular cheilitis, KP, and perianal skin findings than those with UC. Perianal disease, psoriasis, and PG are associated with more severe IBD.
Variable Return to Play and Sport Performance After Elbow Ulnar Collateral Ligament Reconstruction in Baseball Players: A Systematic Review
Hones, Keegan M. , Kamarajugadda, Sravya , Buchanan, Timothy R. , Portnoff, Brandon , Hao, Kévin A. , Kim, Jongmin , King, Joseph J. , Wright, Thomas W. , Aibinder, William R. , King, Joseph J , Hao, Kevin A , Aibinder, William R , Hones, Keegan M , Wright, Jonathan O. , Schoch, Bradley S.

Arthroscopy | February 8, 2024 | Volume: 40 | Issue: 7 | Pages: 1997

10.1016/j.arthro.2024.01.033 | PMID 38340970 Get It

Purpose To evaluate return to play (RTP) and return to same level of play (RTSP) rates as well as preoperative and postoperative in‐game performance metrics in baseball pitchers who underwent ulnar collateral ligament reconstruction (UCLR). Secondarily, this review sought to assess outcomes based on primary versus revision UCLR as well as level of competition. Methods This review was performed using Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines. PubMed/MEDLINE, Embase, Web of Science, and Cochrane Database of Systematic Reviews were queried to identify articles evaluating UCLR in baseball players between January 2002 and October 2022. Data included RTP, RTSP, and performance metrics including earned run average, innings pitched, walks and hits per inning pitched, batting average against, strikeouts per 9 innings, walks per 9 innings, percentage of fastballs thrown, and average fastball velocity. The Methodological Index for Non‐randomized Studies criteria were used for quality assessment. Results Analysis included 25 articles reporting on 2,100 elbows. After primary UCLR, RTP ranged from 336 to 615 days (57% to 100% achieved) and RTSP ranged from 330 to 513 days (61% to 95%). After revision UCLR, RTP ranged from 381 to 631 days (67% to 98%) and RTSP ranged from 518 to 575 days (42% to 78%). When stratifying primary UCLR outcomes by competitive level, RTP and RTSP ranged respectively from 417 to 615 days (75% to 100%) and 513 days (73% to 87%) for Major League Baseball only, 409 to 615 days (57% to 100%) and 470 to 513 days (61% to 95%) for Major League Baseball plus Minor League Baseball, and 336 to 516 days (73% to 85%) and 330 days (55% to 74%) for college plus high school. Heterogeneity was seen in postoperative sports performance metrics. Conclusions Although more than half of baseball players appear able to RTP after primary and revision UCLR, RTSP rates after revision UCLR were as low as 42% in the literature. Preoperative and postoperative performance metrics varied. Level of Evidence Level IV, systematic review of Level II‐IV studies.
Metabolomic biomarkers for (R, S)‐ketamine and (S)‐ketamine in treatment‐resistant depression and healthy controls: A systematic review
Kumar, Rakesh , Núñez, Nicolás A. , Joshi, Neha , Verde, Alessandra , Seshadri, Ashok , Singh, Balwinder , Joseph, Boney , Verde, Alessandra , Singh, Balwinder , Kumar, Rakesh , Joshi, Neha S , Joseph, Boney , Cuéllar‐Barboza, Alfredo B. , Prokop, Larry J. , Medeiros, Gustavo C.

Bipolar Disorders | February 8, 2024 | Volume: 26 | Issue: 4 | Pages: 321-330

10.1111/bdi.13412 | PMID 38326104 Get It

AbstractBackgroundKetamine is increasingly used for treatment‐resistant depression (TRD) while its mechanism of action is still being investigated. In this systematic review, we appraise the current evidence of metabolomic biomarkers for racemic ketamine and esketamine in patients with TRD and healthy controls (HCs).MethodsA comprehensive search of several databases (Ovid MEDLINE®, Embase, and Epub Ahead of Print) was performed from each database's inception to June 29, 2022, in any language, was conducted. We included studies wherein the metabolomic biomarkers for racemic ketamine or esketamine were investigated in TRD or HCs. Our main outcomes were to examine changes in metabolites among patients treated with ketamine/esketamine and explore the association with response to ketamine/esketamine.ResultsA total of 1859 abstracts were screened of which 11 were included for full‐text review. Of these, a total of five articles were included (N = 147), including three RCTs (n = 129) and two open‐label trials (n = 18). All studies used racemic ketamine; one study additionally used esketamine. The included studies evaluated patients with treatment‐resistant bipolar depression (n = 22), unipolar depression (n = 91), and HCs (n = 34). The included studies reported alteration in several metabolites including acylcarnitines, lipids, kynurenine (KYN), and arginine with ketamine in TRD. Studies suggest the involvement of energy metabolism, KYN, and arginine pathways. In HCs, acetylcarnitine decreased post‐infusion, whereas inconsistent findings were observed after the ketamine infusion in TRD patients.ConclusionsThis systematic review provides preliminary evidence that ketamine may cause changes in several important pathways involved in energy metabolism and inflammation. Larger and more rigorous studies are needed.